1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > France Genetic Testing Market Outlook to 2021

France Genetic Testing Market Outlook to 2021

  • September 2015
  • -
  • GlobalData
  • -
  • 35 pages

France Genetic Testing Market Outlook to 2021

Summary

GlobalData’s new report, "France Genetic Testing Market Outlook to 2021", provides key market data on the France Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Genetic Testing market.
- Global corporate-level profiles of key companies operating within the France Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

France Genetic Testing Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Genetic Testing Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Genetic Testing Market, France 7
3.1 Genetic Testing Market, France, Revenue ($m), 2007-2014 7
3.2 Genetic Testing Market, France, Revenue ($m), 2014-2021 9
3.3 Genetic Testing Market, France, Distribution Share by Revenue ($m), 2013-2014 11
3.4 Genetic Testing Market, France, Company Share by Revenue ($m), 2014 12
4 Overview of Key Companies in France, Genetic Testing Market 14
4.1 Abbott Laboratories 14
4.1.1 Company Overview 14
4.2 F. Hoffmann-La Roche Ltd. 14
4.2.1 Company Overview 14
4.3 Danaher Corporation 14
4.3.1 Company Overview 14
4.4 Hologic, Inc. 15
4.4.1 Company Overview 15
4.5 Qiagen N.V. 15
4.5.1 Company Overview 15
4.6 Siemens Healthcare 15
4.6.1 Company Overview 15
4.7 PerkinElmer, Inc. 16
4.7.1 Company Overview 16
4.8 Bio-Rad Laboratories, Inc. 16
4.8.1 Company Overview 16
4.9 Transgenomic, Inc. 16
4.9.1 Company Overview 16
5 Genetic Testing Market Pipeline Products 17
6 Financial Deals Landscape 21
6.1 Asset Transactions 21
6.1.1 Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 21
6.2 Merger 23
6.2.1 Biosynex to Merge with Prodiag 23
6.3 Partnerships 24
6.3.1 KromaTiD Enters into Distribution Agreement with Tebu-bio 24
6.3.2 Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 25
7 Recent Developments 26
7.1 Financial Announcements 26
7.1.1 Apr 01, 2015: The Medicines Company Settles Angiomax (Bivalirudin) Patent Litigation With Sun 26
7.1.2 Mar 26, 2015: Diaxonhit Announces 2014 Annual Results 28
7.1.3 Jan 26, 2015: DIAXONHIT - 2014 Consolidated Income 30
7.2 Other Significant Developments 31
7.2.1 Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test 31
8 Appendix 32
8.1 Research Methodology 33
8.1.1 Coverage 33
8.1.2 Secondary Research 33
8.1.3 Primary Research 33
8.1.4 Company Share Analysis 34
8.1.5 Distribution Share Analysis 34
8.2 GlobalData Consulting 34
8.3 Contact Us 34
8.4 Disclaimer 35

1.1 List of Tables
Table 1: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Genetic Testing Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 11
Table 4: Genetic Testing Market, France, Company Share by Revenue ($m), USD Constant, 2014 13
Table 5: Genetic Testing Market Pipeline Products 17
Table 6: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 21
Table 7: Biosynex to Merge with Prodiag 23
Table 8: KromaTiD Enters into Distribution Agreement with Tebu-bio 24
Table 9: Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 25

1.2 List of Figures
Figure 1: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Genetic Testing Market, France, Company Share (%) 2014 12

Companies Mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Hologic, Inc.
Qiagen N.V.
Siemens Healthcare
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
Transgenomic, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2017 to 2020

  • $ 5495
  • Industry report
  • March 2017
  • by Howe Sound Research

“Genomic Discoveries and Direct to Consumer Drive Growth in a New Genetic Testing Industry....” Will all newborns receive Whole Genomic Sequencing at birth? How fast will Direct to Consumer Testing ...

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing ...

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.